↓ Skip to main content

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe…

Overview of attention for article published in Respiratory Research, October 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
131 Mendeley
Title
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Published in
Respiratory Research, October 2020
DOI 10.1186/s12931-020-01526-6
Pubmed ID
Authors

Andrew Menzies-Gow, Gene Colice, Janet M. Griffiths, Gun Almqvist, Sandhia Ponnarambil, Primal Kaur, Gennaro Ruberto, Karin Bowen, Åsa Hellqvist, May Mo, Esther Garcia Gil

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 131 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 13%
Other 12 9%
Student > Master 12 9%
Student > Bachelor 8 6%
Student > Ph. D. Student 6 5%
Other 12 9%
Unknown 64 49%
Readers by discipline Count As %
Medicine and Dentistry 29 22%
Nursing and Health Professions 9 7%
Biochemistry, Genetics and Molecular Biology 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Immunology and Microbiology 4 3%
Other 10 8%
Unknown 66 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2023.
All research outputs
#3,276,934
of 25,387,668 outputs
Outputs from Respiratory Research
#405
of 3,063 outputs
Outputs of similar age
#82,197
of 435,508 outputs
Outputs of similar age from Respiratory Research
#16
of 92 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,063 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,508 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.